These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30615535)

  • 1. Top-Funded Digital Health Companies And Their Impact On High-Burden, High-Cost Conditions.
    Safavi K; Mathews SC; Bates DW; Dorsey ER; Cohen AB
    Health Aff (Millwood); 2019 Jan; 38(1):115-123. PubMed ID: 30615535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promise of biomedical innovation.
    Weil AR
    Health Aff (Millwood); 2015 Feb; 34(2):198. PubMed ID: 25646097
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategic Opportunities for Leveraging Low-cost, High-impact Technological Innovations to Promote Cardiovascular Health in India.
    Prabhakaran D; Ajay VS; Tandon N
    Ethn Dis; 2019; 29(Suppl 1):145-152. PubMed ID: 30906163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to compete with Google and Co.: big data and artificial intelligence in stones.
    Schoenthaler M; Boeker M; Horki P
    Curr Opin Urol; 2019 Mar; 29(2):135-142. PubMed ID: 30531434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Market watch: a framework for biomedical innovation in emerging markets.
    Gautam A; Yang S
    Nat Rev Drug Discov; 2014 Sep; 13(9):646-7. PubMed ID: 25176427
    [No Abstract]   [Full Text] [Related]  

  • 6. Fostering healthcare innovation in public hospitals: the Queensland experience.
    Mundy L; Howard S; McQueen L; Thomson J; Hewson K
    Aust Health Rev; 2019 Jan; 43(6):672-675. PubMed ID: 30196806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Spending Growth Rates For Key Diseases In 2000-14 Were Driven By Technology And Demographic Factors.
    Dunn A; Whitmire B; Batch A; Fernando L; Rittmueller L
    Health Aff (Millwood); 2018 Jun; 37(6):915-924. PubMed ID: 29863919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High technology health care.
    Lamm RD
    Natl Forum; 1989; 69(4):14-7. PubMed ID: 16100835
    [No Abstract]   [Full Text] [Related]  

  • 9. Accelerating Innovation in Ophthalmic Digital Health: New Frontiers for Medical Devices.
    Bodnar ZM; Tarver ME; Eydelman M
    JAMA Ophthalmol; 2017 Dec; 135(12):1291-1292. PubMed ID: 29075778
    [No Abstract]   [Full Text] [Related]  

  • 10. Digital diabetes: Perspectives for diabetes prevention, management and research.
    Fagherazzi G; Ravaud P
    Diabetes Metab; 2019 Sep; 45(4):322-329. PubMed ID: 30243616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medico-economic evaluation of healthcare products. Methodology for defining a significant impact on French health insurance costs and selection of benchmarks for interpreting results.
    Dervaux B; Baseilhac E; Fagon JY; ; Biot C; Blachier C; Braun E; Debroucker F; Detournay B; Ferretti C; Granger M; Jouan-Flahault C; Lussier MD; Meyer A; Muller S; Pigeon M; De Sahb R; Sannié T; Sapède C; Vray M
    Therapie; 2014; 69(4):323-8. PubMed ID: 25230355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to health care innovation: Regina Herzlinger warns that innovators need to know what obstacles they face and how to overcome them.
    Herzlinger R;
    IEEE Pulse; 2014; 5(1):43-5. PubMed ID: 25296372
    [No Abstract]   [Full Text] [Related]  

  • 13. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is an appropriate level of evidence for a digital health intervention?
    Greaves F; Joshi I; Campbell M; Roberts S; Patel N; Powell J
    Lancet; 2019 Dec; 392(10165):2665-2667. PubMed ID: 30545779
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors Affecting Venture Funding of Healthcare AI Companies.
    Halminen O; Tenhunen H; Heliste A; Seppälä T
    Stud Health Technol Inform; 2019 Jul; 262():268-271. PubMed ID: 31349319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging Artificial Intelligence and Digital Health to Address Health-Related Social Needs and Optimize Risk-Based Value in Orthopaedic Surgery.
    Pean CA; Bessias S; Khan K; Premkumar A
    Instr Course Lect; 2024; 73():77-84. PubMed ID: 38090888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the NHS be a learning healthcare system in the age of digital technology?
    Banerjee A; Drumright LN; Mitchell ARJ
    BMJ Evid Based Med; 2018 Oct; 23(5):161-165. PubMed ID: 29959156
    [No Abstract]   [Full Text] [Related]  

  • 18. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Applying Big Data in Smart Healthcare].
    Chu KC; Xiao MY
    Hu Li Za Zhi; 2020 Oct; 67(5):19-25. PubMed ID: 32978762
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.